Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gymnema sylvestre is a perennial woody climbing plant native to Asia (including India), Africa and Australia. It has been used for centuries in Ayurvedic medicine primarily for the management of diabetes mellitus and related metabolic disorders. The leaves and extracts contain gymnemic acids—triterpenoid saponins that are the major bioactive constituents—which interact with taste receptors on the tongue to temporarily suppress sweet taste perception. Gymnemic acids also reduce intestinal absorption of sugar molecules by binding to receptors on intestinal walls and may stimulate insulin secretion by promoting pancreatic cell growth or regeneration. Modern uses include support for blood sugar control in diabetes and prediabetes; weight loss; reduction of cholesterol levels; appetite suppression; digestive stimulation; anti-inflammatory effects; antibacterial activity (notably against Streptococcus mutans); hepatoprotective effects; diuretic action; laxative effect; and as an adjunct in metabolic syndrome management[1][2][3][5][6][7][8][9]. Most evidence comes from animal studies or small clinical trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gymnema sylvestre.